Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulze-Koops

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Infection|May 14, 2008
Tuberculous spondylitis (Pott's disease)A P Nigg, H Schulze-Koops, S Wirth, et al.
Infection and Immunity|June 1, 1992
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagenH Schulze-Koops, H Burkhardt, J Heesemann, et al.
Clinical and Experimental Rheumatology|July 28, 2010
Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PETM Czihal, F Tatò, S Förster, et al.
Arthritis and Rheumatism|September 1, 1995
Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagenH Schulze-Koops, H Burkhardt, J Heesemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activationA Skapenko, P E Lipsky, H G Kraetsch, et al.
Arthritis and Rheumatism|January 20, 1998
Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 productionX Tao, H Schulze-Koops, L Ma, et al.
Rheumatology (Oxford, England)|February 8, 2006
Combination of immunoadsorption and CD20 antibody therapy in a patient with mixed connective tissue diseaseJ Rech, S Kallert, A J Hueber, et al.
Annals of the Rheumatic Diseases|March 15, 2006
Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiencyJ Rech, A J Hueber, S Kallert, et al.
The Journal of Rheumatology|November 18, 1998
Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4H Schulze-Koops, L S Davis, T P Haverty, et al.
Rheumatology (Oxford, England)|March 27, 2007
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritisR B Mueller, A Skapenko, J Wendler, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Infection|May 14, 2008
Tuberculous spondylitis (Pott's disease)A P Nigg, H Schulze-Koops, S Wirth, et al.
Infection and Immunity|June 1, 1992
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagenH Schulze-Koops, H Burkhardt, J Heesemann, et al.
Clinical and Experimental Rheumatology|July 28, 2010
Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PETM Czihal, F Tatò, S Förster, et al.
Arthritis and Rheumatism|September 1, 1995
Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagenH Schulze-Koops, H Burkhardt, J Heesemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activationA Skapenko, P E Lipsky, H G Kraetsch, et al.
Arthritis and Rheumatism|January 20, 1998
Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 productionX Tao, H Schulze-Koops, L Ma, et al.
Rheumatology (Oxford, England)|February 8, 2006
Combination of immunoadsorption and CD20 antibody therapy in a patient with mixed connective tissue diseaseJ Rech, S Kallert, A J Hueber, et al.
Annals of the Rheumatic Diseases|March 15, 2006
Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiencyJ Rech, A J Hueber, S Kallert, et al.
The Journal of Rheumatology|November 18, 1998
Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4H Schulze-Koops, L S Davis, T P Haverty, et al.
Rheumatology (Oxford, England)|March 27, 2007
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritisR B Mueller, A Skapenko, J Wendler, et al.
Pageof 11